Skip to main content
. 2022 May 15;14(5):3494–3515.

Table 1.

Baseline characteristics of patients with non-muscular invasive bladder cancer (NMIBC) and non-metastatic muscle invasive bladder cancer (non-MMIBC)

Variables Total <1 year 1-3 years 3-5 years 5-10 years >10 year






Patients Deaths SMR Patients Deaths SMR Patients Deaths SMR Patients Deaths SMR Patients Deaths SMR Patients Deaths SMR
NMIBC
    Total 111784 44638 1.40# (1.38/1.41) 111784 5230 1.45# (1.41/1.49) 106181 11700 1.43# (1.4/1.45) 93500 9802 1.40# (1.38/1.43) 68316 14117 1.36# (1.34-1.38) 24255 3789 1.36# (1.31-1.4)
Age
    15-54 years 12617 1394 2.03# (1.93-2.14) 12617 110 2.36# (1.94-2.85) 12431 314 2.54# (2.27-2.84) 11931 269 2.14# (1.9-2.42) 9850 502 1.85# (1.69-2.02) 4804 199 1.67# (1.45-1.92)
    55-64 years 24077 4840 1.73# (1.68-1.78) 24077 387 1.80# (1.63-1.99) 23590 1079 1.94# (1.83-2.06) 22251 1023 1.88# (1.77-2) 17429 1764 1.66# (1.58-1.74) 7372 587 1.40# (1.29-1.51)
    65-74 years 33685 11588 1.50# (1.47-1.53) 33685 957 1.50# (1.4-1.59) 32644 2645 1.62# (1.56-1.69) 29747 2511 1.62# (1.55-1.68) 21895 4101 1.45# (1.4-1.49) 7561 1374 1.28# (1.21-1.35)
    75-84 years 29770 17497 1.20# (1.18-1.21) 29770 1969 1.40# (1.33-1.46) 27718 4514 1.27# (1.23-1.31) 22996 3849 1.14# (1.11-1.18) 15699 5740 1.11# (1.08-1.14) 4137 1425 1.29# (1.22-1.36)
    85+ years 11621 9319 1.52# (1.49-1.55) 11621 1807 1.40# (1.34-1.47) 9784 3148 1.35# (1.3-1.4) 6562 2150 1.55# (1.49-1.62) 3431 2010 1.93# (1.84-2.01) 376 204 2.97# (2.58-3.41)
Sex
    Male 86021 34976 1.39# (1.38-1.4) 86021 3855 1.34# (1.3-1.39) 81904 9224 1.41# (1.39-1.44) 71967 7894 1.43# (1.4-1.46) 52204 11098 1.37# (1.34-1.4) 18341 2905 1.34# (1.29-1.39)
    Female 25763 9662 1.42# (1.39-1.45) 25763 1375 1.87# (1.77-1.97) 24277 2476 1.48# (1.42-1.54) 21533 1908 1.30# (1.24-1.36) 16112 3019 1.33# (1.28-1.37) 5914 884 1.41# (1.32-1.5)
Race
    White 101420 40699 1.37# (1.36-1.38) 101420 4644 1.39# (1.35-1.43) 96470 10617 1.40# (1.37-1.42) 85023 8953 1.38# (1.35-1.41) 62291 12998 1.34# (1.32-1.37) 22171 3487 1.34# (1.3-1.39)
    Black 5440 2320 1.72# (1.65-1.79) 5440 373 2.27# (2.04-2.51) 5042 654 1.82# (1.68-1.96) 4339 497 1.70# (1.56-1.86) 3078 624 1.48# (1.37-1.61) 1052 172 1.54# (1.32-1.79)
274 111 3.60# (2.96-4.33) 274 18 4.71# (2.79-7.44) 255 25 2.93# (1.9-4.32) 223 26 4.22# (2.76-6.19) 148 30 3.12# (2.11-4.46) 53 12 4.40# (2.27-7.68)
    Asian or Pacific Islander 4650 1508 1.72# (1.63-1.81) 4650 195 1.97# (1.7-2.26) 4414 404 1.79# (1.62-1.97) 3915 326 1.69# (1.51-1.89) 2799 465 1.66# (1.51-1.81) 979 118 1.50# (1.24-1.79)
Differentiation
    Grade I 17233 6102 1.20# (1.17-1.24) 17233 505 1.02 (0.93-1.11) 16657 1367 1.16# (1.1-1.23) 15161 1315 1.21# (1.15-1.28) 12187 2182 1.25# (1.2-1.3) 4981 733 1.31# (1.21-1.41)
    Grade II 33904 12445 1.22# (1.2-1.25) 33904 1069 1.06 (1-1.13) 32737 2721 1.14# (1.1-1.18) 29730 2625 1.25# (1.21-1.3) 21816 4527 1.27# (1.24-1.31) 9767 1503 1.34# (1.28-1.41)
    Grade III 14851 7448 1.60# (1.56-1.64) 14851 1044 1.96# (1.84-2.08) 13757 1989 1.71# (1.63-1.78) 11682 1492 1.49# (1.42-1.57) 9074 2280 1.51# (1.44-1.57) 3553 643 1.45# (1.34-1.56)
    Grade IV 23627 10430 1.67# (1.64-1.71) 23627 1525 1.82# (1.73-1.91) 22013 3318 1.82# (1.76-1.88) 18446 2378 1.71# (1.64-1.78) 11443 2666 1.48# (1.43-1.54) 3359 543 1.41# (1.29-1.53)
T stage
    Ta 71504 25213 1.21# (1.19-1.22) 71504 2154 0.97 (0.93-1.01) 69140 6022 1.15# (1.12-1.18) 62475 5701 1.24# (1.21-1.27) 46328 8868 1.27# (1.25-1.3) 16766 2468 1.30# (1.25-1.35)
    Tis 7385 3205 1.37# (1.33-1.42) 7385 315 1.26# (1.13-1.41) 7046 780 1.36# (1.26-1.45) 6215 706 1.42# (1.32-1.53) 4634 1107 1.41# (1.33-1.49) 1753 297 1.31# (1.16-1.46)
    T1 31804 15561 1.84# (1.81-1.86) 31804 2524 2.31# (2.22-2.4) 29146 4707 2.03# (1.97-2.09) 24159 3289 1.78# (1.72-1.85) 16920 4043 1.57# (1.53-1.62) 5608 998 1.53# (1.43-1.62)
Pathology
    Papillary transitional cell carcinoma 92360 35229 1.32# (1.3-1.33) 92360 3451 1.17# (1.13-1.21) 88603 8967 1.32# (1.29-1.34) 78818 7911 1.35# (1.32-1.38) 57931 11690 1.33# (1.31-1.36) 20886 3210 1.35# (1.3-1.39)
    Transitional cell carcinoma 16766 7949 1.76# (1.72-1.79) 16766 1307 2.29# (2.17-2.42) 15409 2352 1.93# (1.85-2.01) 12913 1681 1.70# (1.62-1.78) 9081 2110 1.51# (1.44-1.57) 2881 499 1.43# (1.31-1.56)
    Papillary carcinoma 527 234 1.40# (1.22-1.59) 527 24 1.46 (0.93-2.17) 502 57 1.53# (1.16-1.98) 443 38 1.19 (0.84-1.64) 354 82 1.37# (1.09-1.7) 181 33 1.50# (1.03-2.1)
    Squamous cell carcinoma 185 146 5.04# (4.26-5.93) 185 76 14.33# (11.29-17.94) 107 36 4.52# (3.17-6.26) 69 14 2.52# (1.38-4.23) 46 16 2.17# (1.24-3.52) 14 4 1.46 (0.4-3.75)
    Adenocarcinoma 183 95 2.48# (2-3.03) 183 26 4.77# (3.12-6.99) 155 23 2.24# (1.42-3.37) 132 25 3.33# (2.16-4.92) 92 17 1.44 (0.84-2.31) 26 4 1.18 (0.32-3.01)
Surgery
    Local tumor excision 102721 40681 1.37# (1.36-1.39) 102721 4424 1.33# (1.29-1.37) 97966 10690 1.41# (1.38-1.43) 86393 8986 1.39# (1.36-1.42) 63073 13046 1.36# (1.33-1.38) 22486 3535 1.36# (1.32-1.41)
    Cystectomy 2428 947 1.72# (1.62-1.84) 2428 127 2.26# (1.88-2.69) 2286 232 1.78# (1.56-2.02) 2027 207 1.74# (1.51-1.99) 1502 312 1.64# (1.46-1.83) 508 69 1.30# (1.01-1.65)
    other 6635 3010 1.66# (1.6-1.72) 6635 679 3.02# (2.8-3.26) 5929 778 1.65# (1.53-1.77) 5080 609 1.55# (1.43-1.68) 3741 759 1.30# (1.21-1.4) 1261 185 1.32# (1.14-1.52)
Chemotherapy
    Yes 16762 5397 1.38# (1.34-1.41) 16762 556 1.13# (1.04-1.22) 16145 1650 1.42# (1.36-1.49) 14317 1335 1.40# (1.33-1.48) 9154 1579 1.40# (1.34-1.47) 2120 277 1.43# (1.26-1.6)
    No/Unknown 95022 39241 1.40# (1.39-1.41) 95022 4674 1.50# (1.46-1.55) 90036 10050 1.43# (1.4-1.46) 79183 8467 1.40# (1.37-1.43) 59162 12538 1.35# (1.33-1.38) 22135 3512 1.35# (1.31-1.4)
Radiation
    yes 111006 43999 1.38# (1.37-1.4) 111006 5037 1.41# (1.37-1.45) 105599 11465 1.41# (1.38-1.43) 93155 9698 1.40# (1.37-1.42) 68114 14026 1.36# (1.33-1.38) 24200 3773 1.36# (1.31-1.4)
    No/Unknown 778 639 3.68# (3.4-3.98) 778 193 5.23# (4.52-6.02) 582 235 4.10# (3.59-4.66) 345 104 3.04# (2.48-3.68) 202 91 2.38# (1.92-2.92) 55 16 2.34# (1.34-3.8)
non-MMIBC
    Total 26546 18829 4.67# (4.6-4.73) 26546 7309 9.62# (9.4-9.84) 19096 6948 6.07# (5.93-6.21) 11935 2159 2.72# (2.61-2.84) 7808 1970 1.85# (1.77-1.93) 2511 443 1.64# (1.49-1.8)
Age
    15-54 years 2535 1331 15.54# (14.72-16.4) 2535 410 44.62# (40.4-49.15) 2116 593 32.27# (29.73-34.98) 1485 170 10.96# (9.38-12.74) 1086 126 4.20# (3.5-5) 491 32 2.54# (1.74-3.59)
    55-64 years 5496 3166 8.56# (8.26-8.86) 5496 975 21.73# (20.38-23.13) 4482 1379 16.01# (15.17-16.88) 3046 379 5.35# (4.82-5.91) 2175 342 2.75# (2.46-3.05) 811 91 2.09# (1.68-2.57)
    65-74 years 7542 4984 5.21# (5.06-5.35) 7542 1652 13.00# (12.38-13.65) 5849 1924 8.13# (7.77-8.5) 3870 631 3.37# (3.11-3.65) 2510 621 2.05# (1.89-2.22) 777 156 1.50# (1.28-1.76)
    75-84 years 7463 6078 3.43# (3.34-3.51) 7463 2539 8.78# (8.44-9.13) 4889 2041 4.17# (3.99-4.35) 2802 678 1.79# (1.66-1.93) 1713 682 1.33# (1.23-1.43) 391 138 1.33# (1.12-1.58)
    85+ years 3510 3270 3.85# (3.72-3.99) 3510 1733 5.98# (5.7-6.27) 1760 1011 3.22# (3.02-3.42) 732 301 2.12# (1.89-2.37) 324 199 2.07# (1.79-2.38) 41 26 3.79# (2.48-5.55)
Sex
    Male 19317 13457 4.36# (4.29-4.44) 19317 4872 8.57# (8.33-8.81) 14353 5123 5.82# (5.67-5.99) 9068 1619 2.65# (2.53-2.79) 5958 1504 1.84# (1.75-1.93) 1918 339 1.63# (1.46-1.81)
    Female 7229 5372 5.65# (5.5-5.81) 7229 2437 12.74# (12.24-13.26) 4743 1825 6.87# (6.56-7.2) 2867 540 2.94# (2.7-3.2) 1850 466 1.88# (1.71-2.06) 593 104 1.67# (1.37-2.03)
Race
    White 23280 16527 4.50# (4.43-4.57) 23280 6381 9.27# (9.05-9.5) 16805 6047 5.81# (5.67-5.96) 10581 1921 2.66# (2.54-2.78) 6924 1783 1.83# (1.74-1.91) 2220 395 1.60# (1.45-1.77)
    Black 1961 1503 6.63# (6.3-6.98) 1961 629 13.42# (12.39-14.51) 1319 585 8.63# (7.94-9.36) 723 141 3.16# (2.66-3.73) 465 120 2.25# (1.86-2.69) 135 28 2.02# (1.34-2.92)
    American Indian-Alaska Native 106 76 15.66# (12.34-19.6) 106 35 26.84# (18.69-37.32) 70 29 17.21# (11.52-24.71) 40 6 7.25# (2.66-15.77) 24 6 6.34# (2.33-13.79) 9 0 0 (0-41.37)
    Asian or Pacific Islander 1199 723 5.55# (5.16-5.97) 1199 264 11.19# (9.88-12.63) 902 287 8.20# (7.28-9.21) 591 91 3.59# (2.89-4.41) 395 61 1.66# (1.27-2.14) 147 20 2.09# (1.27-3.22)
Differentiation
    Grade I 316 196 3.05# (2.64-3.51) 316 66 8.11# (6.27-10.32) 247 58 3.86# (2.93-4.99) 187 20 1.5 (0.92-2.32) 146 41 1.89# (1.35-2.56) 50 11 1.83 (0.91-3.27)
    Grade II 1473 1007 4.09# (3.84-4.35) 1473 362 9.44# (8.5-10.47) 1102 313 4.84# (4.32-5.41) 775 145 2.99# (2.52-3.52) 546 152 2.13# (1.8-2.49) 197 35 1.51# (1.05-2.1)
    Grade III 8222 6220 4.71# (4.59-4.83) 8222 2410 10.06# (9.66-10.47) 5768 2252 6.46# (6.19-6.73) 3456 663 2.66# (2.46-2.87) 2486 706 1.87# (1.74-2.02) 977 189 1.77# (1.53-2.04)
    Grade IV 14765 10146 4.67# (4.58-4.76) 14765 3886 9.21# (8.92-9.5) 10809 3889 6.05# (5.86-6.24) 6802 1199 2.76# (2.61-2.92) 4188 982 1.80# (1.69-1.91) 1199 190 1.51# (1.3-1.74)
T
    T2a 4651 2918 3.57# (3.44-3.7) 4651 962 6.52# (6.11-6.94) 3673 1067 4.36# (4.1-4.63) 2562 411 2.38# (2.15-2.62) 1685 386 1.86# (1.68-2.06) 444 92 2.01# (1.62-2.47)
    T2b 3899 2622 4.08# (3.93-4.24) 3899 960 8.49# (7.96-9.05) 2911 959 5.67# (5.31-6.04) 1908 312 2.51# (2.24-2.81) 1325 304 1.67# (1.49-1.87) 486 87 1.62# (1.3-2)
    T3a 3016 2116 5.01# (4.8-5.23) 3016 666 9.65# (8.93-10.41) 2340 894 7.90# (7.39-8.44) 1426 257 2.98# (2.63-3.37) 939 249 2.01# (1.77-2.28) 288 50 1.63# (1.21-2.15)
    T3b 1552 1163 6.48# (6.12-6.87) 1552 463 13.38# (12.19-14.66) 1084 494 10.17# (9.29-11.11) 581 90 2.63# (2.11-3.23) 371 97 1.92# (1.55-2.34) 102 19 1.68# (1.01-2.62)
    T4a 3076 2514 7.19# (6.92-7.48) 3076 1106 14.83# (13.97-15.73) 1950 931 9.28# (8.69-9.89) 1002 258 3.92# (3.46-4.43) 615 188 2.16# (1.87-2.5) 216 31 1.42 (0.96-2.01)
    T4b 655 599 24.19# (22.29-26.21) 655 396 42.31# (38.24-46.69) 252 167 23.93# (20.43-27.84) 81 22 6.85# (4.29-10.36) 50 13 3.23# (1.72-5.53) 19 1 0.84 (0.02-4.71)
N
    N0 22110 15233 4.17# (4.1-4.23) 22110 5827 8.69# (8.47-8.92) 16166 5371 5.19# (5.05-5.33) 10613 1844 2.54# (2.43-2.66) 7033 1782 1.82# (1.74-1.91) 2248 409 1.66# (1.5-1.83)
    N1 2066 1605 8.52# (8.11-8.95) 2066 608 15.56# (14.35-16.85) 1450 715 13.52# (12.55-14.55) 720 164 4.80# (4.09-5.59) 440 101 2.09# (1.71-2.55) 160 17 1.21 (0.71-1.94)
    N2 1823 1527 12.51# (11.89-13.15) 1823 645 19.95# (18.44-21.55) 1168 704 20.00# (18.55-21.53) 449 114 5.37# (4.43-6.45) 245 56 2.07# (1.57-2.69) 70 8 1.27 (0.55-2.5)
    N3 69 62 14.70# (11.27-18.85) 69 29 22.08# (14.79-31.71) 40 26 17.87# (11.67-26.18) 14 5 6.39# (2.07-14.91) 3 2 3 (0.36-10.85) 0 0 0 (0-0)
Pathology
    Transitional cell carcinoma 14794 10692 5.02# (4.93-5.12) 14794 4321 10.29# (9.99-10.6) 10400 4026 6.68# (6.48-6.89) 6252 1114 2.70# (2.54-2.86) 4089 1006 1.82# (1.71-1.94) 1305 225 1.58# (1.38-1.81)
    Papillary transitional cell carcinoma 8540 5761 3.69# (3.6-3.79) 8540 1821 6.69# (6.39-7) 6671 2166 4.82# (4.62-5.03) 4435 814 2.59# (2.42-2.78) 2921 778 1.86# (1.73-1.99) 961 182 1.72# (1.48-1.99)
    Squamous cell carcinoma 765 615 7.66# (7.07-8.29) 765 374 23.87# (21.51-26.41) 385 147 7.92# (6.69-9.31) 237 36 2.31# (1.62-3.2) 173 51 2.12# (1.58-2.79) 52 7 1.09 (0.44-2.24)
    Small cell carcinoma 421 317 6.44# (5.75-7.19) 421 144 13.90# (11.72-16.37) 276 119 8.74# (7.24-10.46) 152 29 3.16# (2.11-4.53) 95 22 1.64# (1.03-2.49) 27 3 1.13 (0.23-3.3)
    Transitional cell carcinoma, spindle cell 263 194 7.43# (6.42-8.55) 263 114 21.65# (17.86-26.01) 147 55 7.32# (5.52-9.53) 90 12 2.22# (1.15-3.89) 65 11 1.72 (0.86-3.07) 15 2 1.29 (0.16-4.65)
Surgery
    Partial cystectomy 1179 713 3.15# (2.92-3.39) 1179 186 5.38# (4.64-6.21) 991 279 4.52# (4-5.08) 699 116 2.35# (1.94-2.81) 477 107 1.66# (1.36-2) 145 25 1.56# (1.01-2.3)
    Radical cystectomy 7360 4668 3.89# (3.78-4.01) 7360 1335 8.81# (8.34-9.29) 5992 1830 6.60# (6.3-6.91) 4107 596 2.53# (2.33-2.74) 3063 714 1.74# (1.61-1.87) 1195 193 1.56# (1.35-1.8)
    Other therapy 14166 11294 5.20# (5.11-5.3) 14166 5101 10.13# (9.85-10.41) 8983 3881 5.75# (5.58-5.94) 4998 1170 2.86# (2.7-3.03) 3028 957 2.00# (1.87-2.13) 897 185 1.77# (1.52-2.04)
Chemotherapy
    Yes 10905 7181 5.11# (4.99-5.23) 10905 2124 8.11# (7.77-8.46) 8740 3320 7.71# (7.45-7.98) 5322 900 3.08# (2.88-3.28) 3165 727 2.09# (1.94-2.25) 783 110 1.54# (1.26-1.85)
    No/Unknown 15641 11648 4.43# (4.35-4.51) 15641 5185 10.41# (10.13-10.7) 10356 3628 5.08# (4.91-5.25) 6613 1259 2.51# (2.38-2.66) 4643 1243 1.73# (1.63-1.83) 1728 333 1.68# (1.5-1.87)
Radiation
    Yes 4693 3858 5.02# (4.86-5.18) 4693 1428 7.50# (7.12-7.9) 3245 1587 6.15# (5.85-6.46) 1628 448 3.02# (2.75-3.31) 887 351 2.34# (2.1-2.6) 182 44 1.95# (1.42-2.62)
    No/Unknown 21853 14971 4.58# (4.51-4.66) 21853 5881 10.33# (10.06-10.59) 15851 5361 6.04# (5.88-6.21) 10307 1711 2.65# (2.53-2.78) 6921 1619 1.77# (1.68-1.85) 2329 399 1.61# (1.46-1.78)

NMIBC: Non-muscular invasive bladder cancer; non-MMIBC: non-metastatic muscle invasive bladder cancer; SMR: Standard Mortality Ratio;

#

significant difference.